Central Nervous System
AstraZeneca’s Ultomiris receives Japanese approval for NMOSD
AstraZeneca has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its Ultomiris (ravulizumab) to prevent…
FDA delays Sarepta’s DMD gene therapy decision until June
Pushing back an initial deadline, the US Food and Drug Administration (FDA) has proposed a new regulatory action date of…
Sun rises on Lithuania’s life sciences industry
Lithuania possesses one of the oldest languages still in use today, a tree which is amongst the most ancient in…
NICE recommends new digital therapies for patients with depression and anxiety
The UK's National Institute of Health and Care Excellence (NICE) has greenlit nine new digital therapies for patients with mental…
FDA AdCom votes in favour of first gene transfer therapy for DMD
In a closely contested debate, a US Food and Drug Administration Advisory Committee (AdCom) panel voted eight to six in…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Eli Lilly’s donanemab makes a splash in Alzheimer’s, but will Medicare cover it?
After the FDA rejected an accelerated approval bid in January, Eli Lilly has returned with topline data proving that donanemab…
Plus Therapeutics and PPS expand partnership for cGMP drug production
Plus Therapeutics has expanded its partnership with Piramal Pharma Solutions (PPS) to produce additional cGMP liposome intermediate drug products. This…
Click Therapeutics kicks off digital therapy remote trial for migraine
Click Therapeutics announced the initiation of a fully remote trial investigating the potential of digital therapeutics to reduce migraine occurrences…
FDA approves IntelGenx’s Rizafilm for acute migraine treatment
IntelGenx Corp announced that the US Food and Drug Administration (FDA) has approved the company’s Rizafilm VersaFilm new drug application…
Pipeline Therapeutics and Janssen partner for neuroscience therapy
Pipeline Therapeutics and Janssen Pharmaceutical have signed a global licence and development agreement for PIPE-307 to treat disorders of the…